Sulzer AG (SUN) Q2 2026 Earnings Report

The call presents a constructive operational and profitability story: strong margin expansion, Flow and Services regaining momentum, and clear execution of Sulzer Excellence and strategic initiatives. However, significant headwinds remain—primarily within Chemtech (large order delays in new technologies), elevated net working capital and free‑cash‑flow pressure, and geopolitical-related project timing risk. Management reiterated its full‑year guidance and expects orders to be back‑loaded into H2/Q4, indicating confidence but also execution risk tied to the timing of large awards.

Sulzer reiterated its February guidance: full‑year 2026 order intake growth of +1% to +5%, sales growth of +2% to +5% and an expected full‑year EBITDA margin of about 16.5%. At midyear the group reported H1 order intake -3.9% (a shortfall of <CHF80m), H1 sales roughly +1% (Flow +0.5%, Services +4.4%, Chemtech -4.9%), H1 EBITDA margin 15.5% (up 110 bps y/y) and an order‑intake margin of 35.7% (down 60 bps); book‑to‑bill is >1 across BUs except new technologies. Management flagged a ~CHF100–117m increase in net working capital (now ~26% of sales vs 22% prior), which reduced free cash flow (cash impact ~CHF40m), an anticipated low‑single‑digit restructuring charge for Chemtech in H2 plus an ~CHF8m impairment, and said large orders are expected to be back‑loaded (likely Q4) while they would not change guidance for a weak Q3.